Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours Β· Estimated delivery Aug 19 - Aug 24
Gastroenterology 133 , 244255 (2007)
There's a needle
Improving affordability, expanding equitable access, and developing care delivery models that support appropriate implementation will be essential to ensure that advances in cardiometabolic therapy translate into meaningful reductions in population-level disease burden rather than primarily benefiting those with greater resources
presented that patients taking GLP-1RAs (exenatide or semaglutide) were four times more likely to have increased RGC during upper endoscopy than control ( OR 4.22
The distinction matters for one practical reason
Early 2023 ASA guidance favored holding daily agents on the day of surgery and weekly agents for one week, but 2024 multi-society guidance now recommends that most patients continue therapy before elective procedures
US$ 27.70
US$ 28.30
US$ 29.45
US$ 25.90
US$ 20.30
US$ 23.69
US$ 24.79
US$ 24.95
US$ 22.05
